This company is no longer active
Salud financiera de hoja de balance de Diffusion Pharmaceuticals
Salud financiera controles de criterios 6/6
Diffusion Pharmaceuticals has a total shareholder equity of $14.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $15.7M and $1.5M respectively.
Información clave
0%
Ratio deuda-patrimonio
US$0
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$15.00m |
| Patrimonio | US$14.23m |
| Total pasivo | US$1.46m |
| Activos totales | US$15.69m |
Actualizaciones recientes sobre salud financiera
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: DP80's short term assets ($15.7M) exceed its short term liabilities ($1.5M).
Pasivo a largo plazo: DP80 has no long term liabilities.
Historial y análisis de deuda-patrimonio
Nivel de deuda: DP80 is debt free.
Reducción de la deuda: DP80 had no debt 5 years ago.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: DP80 has sufficient cash runway for more than a year based on its current free cash flow.
Pronóstico de cash runway: DP80 has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 6.4% each year.